Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06720142 · ClinicalTrials.gov registry record

Mg OSTEOCRETE Post-Treatment Outcomes

A clinical trial of Trauma and Cancer of Bone, sponsored by Santiago Lozano-Calderon.

Recruiting
Registry status
10
Enrollment target
1
Study location

NCT06720142 is a study of Trauma and Cancer of Bone that is actively recruiting participants, run by Santiago Lozano-Calderon. The registered enrollment target is 10 participants, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06720142, a study of Trauma and Cancer of Bone, is actively recruiting participants, sponsored by Santiago Lozano-Calderon.

RECRUITING
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

Interventions

  • DEVICE Mg OSTEOCRETE as a bone void filler

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-03-17
Est. Completion 2026-06

Sponsor

Santiago Lozano-Calderon

1 total trials

What the Registry Record Tells You About NCT06720142

The ClinicalTrials.gov registry entry for NCT06720142 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 307-participant average among 56 other Trauma trials with a reported enrollment target (97% lower). The listed sponsor is Santiago Lozano-Calderon, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Trauma appearing as the primary indexed condition, and to 1 intervention - of which Mg OSTEOCRETE as a bone void filler is the first listed.

NCT06720142 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06720142 about?

NCT06720142 is a clinical study titled "Mg OSTEOCRETE Post-Treatment Outcomes". Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to ...

What is the current status of trial NCT06720142?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2025-03-17. Estimated completion is 2026-06.

What conditions does trial NCT06720142 study?

This clinical trial studies the following conditions: Trauma, Cancer of Bone, Aseptic Loosening of Orthopaedic Hardware.

What interventions are being tested in trial NCT06720142?

The interventions under investigation include: Mg OSTEOCRETE as a bone void filler (DEVICE).

Who is sponsoring clinical trial NCT06720142?

This trial is sponsored by Santiago Lozano-Calderon, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06720142 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.